A Study Assessing Circulation Around Surgical Incisions at the Time of Laparotomy Closure

NCT ID: NCT03408366

Last Updated: 2022-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-15

Study Completion Date

2022-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being done to find out if Spectrum Near-Infrared (NIR) imaging with Indocyanine Green (ICG) dye can help measure blood flow around an incision before and after the surgeon closes the incision with staples or sutures.

The Spectrum NIR imaging system uses a handheld camera that produces a special type of light that can help surgeons see things during surgery that are difficult to see with the naked eye, for example, cancer tissue versus healthy tissue. Spectrum NIR imaging has been approved by the Food and Drug Administration (FDA) as a tool that is widely used during surgery.

ICG dye is a sterile solution that can be seen with Spectrum NIR imaging. This dye, used with Spectrum NIR imaging, allows surgeons to see blood flow to parts of the body during and after surgery. Making sure that there is enough blood flow to the surgical site helps to promote a less complicated recovery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laparotomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Twenty consecutive patients will be enrolled: the first 10 will have skin closure with staples, and the second 10 will have skin closure with a running subcuticular suture.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women having a Laparotomy

The first 10 patients enrolled will undergo skin closure with staples. The next 10 patients enrolled will undergo skin closure with a running subcuticular suture.to evaluate skin perfusion using the Spectrum NIR imaging system following intravenous injection of ICG in all patients. Patients will be assigned skin closure with either running subcuticular suture or skin staples in a sequential, nonrandomized fashion before the procedure. After the planned surgical procedure is complete, ICG will be injected intravenously. Video of the incision will be recorded. After skin closure is complete, a second intravenous bolus of ICG (same dose as previously injected) will be given. Video of the incision will again be recorded. Measurement of perfusion will subsequently be performed by video analysis at the previously described three predefined points along the incision after surgery is complete and again after skin closure.

Group Type EXPERIMENTAL

Laparotomy

Intervention Type PROCEDURE

Laparotomy via vertical midline incision and after the planned surgical procedure is complete.

ICG

Intervention Type OTHER

ICG will be injected intravenously ICG is a fluorescent iodide dye.

Spectrum NIR imaging system

Intervention Type OTHER

The Spectrum NIR imaging system uses a handheld camera that emits light in the NIR range.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laparotomy

Laparotomy via vertical midline incision and after the planned surgical procedure is complete.

Intervention Type PROCEDURE

ICG

ICG will be injected intravenously ICG is a fluorescent iodide dye.

Intervention Type OTHER

Spectrum NIR imaging system

The Spectrum NIR imaging system uses a handheld camera that emits light in the NIR range.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Woman undergoing a laparotomy procedure via a vertical midline incision for any indication with the Gynecology Service at MSK
* Age ≥18 years


* Woman undergoing a laparotomy procedure via a vertical midline incision for any indication with the Gynecology Service at MSK
* Age ≥18 years

Exclusion Criteria

* Women with hepatic dysfunction as evidenced by elevated transaminases
* Women with a history of cirrhosis or other chronic liver disease
* Women with an allergy to iodine
* Women undergoing laparoscopic or minimally invasive surgery

Criteria for Eligibility Post-Surgery


* Women with laparotomy incisions unable to be closed primarily due to tissue or fascial damage
* Women with transverse laparotomy incisions
* Women with laparotomy incisions left open due to a case classification as "contaminated" or "dirty"
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Memorial Sloan Kettering Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nadeem Abu-Rustum, MD

Role: PRINCIPAL_INVESTIGATOR

Memorial Sloan Kettering Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Memoral Sloan Kettering Basking Ridge (Consent only)

Basking Ridge, New Jersey, United States

Site Status

Memoral Sloan Kettering Monmouth (Consent only)

Middletown, New Jersey, United States

Site Status

Memorial Sloan Kettering Bergen (Consent only )

Montvale, New Jersey, United States

Site Status

Memorial Sloan Kettering Commack (Consent only)

Commack, New York, United States

Site Status

Memoral Sloan Kettering Westchester (Consent only)

Harrison, New York, United States

Site Status

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Site Status

Memorial Sloan Kettering Rockville Centre (Consent only)

Rockville Centre, New York, United States

Site Status

Memorial Sloan Kettering Nassau (Consent only)

Uniondale, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mskcc.org/mskcc/html/44.cfm

Memorial Sloan Kettering Cancer Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-650

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NIRS and DO2i Correlation
NCT03281707 UNKNOWN